Spots Global Cancer Trial Database for Immune Checkpoint Inhibitors and Pre-existing Autoimmune Diseases
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: Immune Checkpoint Inhibitors and Pre-existing Autoimmune Diseases
Official Title: Retrospective Observational Study on the Safety of Immune Checkpoint Inhibitors in the Treatment of Advanced Melanoma and Lung Cancers in Patients With Pre-Existing Autoimmune Diseases
Study ID: NCT03140137
Interventions
Study Description
Brief Summary: The tolerance of immune checkpoint inhibitors is unknown in patients with pre-existing autoimmune conditions. This retrospective nation-wide study will assess their tolerance in patients with pre-existing autoimmune conditions who received immune checkpoint inhibitors for an advanced cancer in clinical practice.
Detailed Description:
Keywords
Eligibility
Minimum Age: 18 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: ALL
Healthy Volunteers: No
Locations
CH d'AIX, AIX en PROVENCE, , France
CHU de DIJON, Dijon, , France
CHD Vendée, La Roche-sur-Yon, , France
Ch Le Mans, Le Mans, , France
CH de MACON, Macon, , France
Contact Details
Name: Divi CORNEC
Affiliation: CHRU de Brest
Role: STUDY_DIRECTOR
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
